Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis)
European Journal of Cancer, Volume 45, No. 7, Year 2009
Notification
URL copied to clipboard!
Description
Although breast needle core biopsy (NCB) is now a standard diagnostic procedure in the triple assessment of screen-detected breast lesions, data on the false-positive diagnoses of malignancy (malignant NCB 'B5' with normal/benign surgery) are lacking. In this study, we have studied a large series of NCBs (101,440) to assess the causes and pitfalls resulting in false-positive NCB diagnoses and to evaluate their impact on patients' management in the screening service. Our results showed that of 40,395 malignant NCBs reported during the period of this study, 174 NCBs are considered as false-positives (0.43%; (95% confidence interval [CI] = 0.37-0.49%)). However, on review, 165 cases (95%) were found to be the result of true removal of the whole lesion in the core with subsequent negative excision biopsy samples (true-positive NCBs). This may reflect sampling of small screen detected lesions and the use of larger core biopsies at assessment. The remaining 9 cases were considered as true false-positive cores, giving a false-positive rate of 0.02% (95% CI = 0.01-0.04%). Analysis of these 9 cases showed that 8 cases, originally diagnosed as DCIS, were classified as borderline lesions or lesions of uncertain malignant potential after surgical excision. The classification and management of such borderline lesions remains controversial and diagnostic surgical excision is usually the optimum management. One case was the result of pathological misinterpretation of fat necrosis as invasive carcinoma. This was the only case that resulted in a significant over-management of the patient. In conclusion, our results showed that the true false-positive rate of NCB is extremely rare. Significant over-management of screen-detected breast lesions as a result of false-positive NCB may be considered almost nil. © 2008 Elsevier Ltd. All rights reserved.
Authors & Co-Authors
Rakha, Emad A.
United Kingdom, Nottingham
University of Nottingham
El-Sayed, Maysa E.
United Kingdom, Nottingham
University of Nottingham
Egypt, Shibin el Kom
Menoufia University Faculty of Medicine
Reed, Jacquie A.
United Kingdom, Nottingham
Nottingham University Hospitals Nhs Trust
Lee, Andrew H.S.
United Kingdom, Nottingham
University of Nottingham
Evans, Andrew J.
United Kingdom, Nottingham
Nottingham University Hospitals Nhs Trust
Ellis, Ian O.
United Kingdom, Nottingham
University of Nottingham
Statistics
Citations: 6
Authors: 6
Affiliations: 3
Identifiers
Doi:
10.1016/j.ejca.2008.12.002
ISSN:
09598049
Research Areas
Cancer
Health System And Policy